Chinook Therapeutics, Inc. announced the appointment of Charlotte Jones-Burton, M.D., M.S. as senior vice president of product development and strategy. Dr. Jones-Burton joins Chinook from Otsuka Pharmaceuticals, where she most recently served as vice president of global clinical development and head of nephrology. She has spent over a decade in the pharmaceutical industry, including at Bristol-Myers Squibb and Merck, where she led clinical trial development for multiple medicines across various disease areas including cardiovascular and renal diseases.
Chinook Therapeutics, Inc.
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.14% | 114B | |
+11.46% | 104B | |
-12.93% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.45% | 17.89B | |
+8.14% | 14.28B | |
+34.79% | 12.55B |